Impact of sustained virologic response (SVR) on mortality in patients with advanced liver disease.
The impact of achieving SVR on all-cause mortality and the incidence
of hepatocellular carcinoma (HCC) was evaluated in a
cohort of more than 15,000 patients with advanced liver disease in
the Veterans Administrations Clinical case registry for hepatitis C.